An Observational Post-Authorisation Safety Study (PASS) of Patients with Chronic Opioid Use for Non-Cancer Pain and Cancer Pain who have Opioid-Induced Constipation (OIC) (Naldemedine PASS)First published 27/09/2021 Last updated 23/04/2024 EU PAS number: EUPAS43258StudyPlanned
United BioSource Corporation (UBC)Switzerland First published: 25/04/2013Last updated 06/03/2024 InstitutionNon-Pharmaceutical companyENCePP partner